Si-Jie Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Si-Jie Liu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ruofeng Shang
Key Laboratory of New Animal Drug Project, Gansu Province/Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs/Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China
3 shared publications - Xiaohui Bai
School of Chemistry and Chemical Engineering, Yulin University , 719000 , Yulin , Shannxi , People’s Republic of China
2 shared publications - Yan Xing
College of Chemistry, Northeast Normal University, Changchun 130024, PR China
2 shared publications - Chao Zhang
Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China
1 shared publication Chenyi Wang
1 shared publicationDavid Chi-Cheong Wan
Department of Biochemistry, The Chinese University of Hong Kong, Hong Kong SAR, China
1 shared publication
Latest Publications
- 15 July 2025
- Published by Elsevier in Ceramics International
- Vol. 51 (25) , 43848-43860
Flower-like In4Se3 anchored on Bi-high entropy materials: A noble metal-modified hybrid for enhanced visible-light photocatalysis
- 15 July 2025
- Published by Elsevier in Ceramics International
- Vol. 51 (25) , 43848-43860
Flower-like In4Se3 anchored on Bi-high entropy materials: A noble metal-modified hybrid for enhanced visible-light photocatalysis
- Open Access
- 17 November 2021
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (1) , 125-127
Crystal structure of 14-O-[(4-(4-hydroxypiperidine-1-yl)-6-methylpyrimidine-2-yl)thioacetyl]-mutilin monohydrate, C32H49N3O6S
C32H49N3O6S, orthorhombic, P212121 (no. 19), a = 9.2618(2) Å, b = 12.4066(2) Å, c = 27.2256(5) Å, V = 3128.42(12) Å3, Z = 4, R gt (F) = 0.0517, wR ref (F 2) = 0.1355, T = 173.20(2) K.
- 17 November 2021
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (1) , 125-127
Open AccessCrystal structure of 14-O-[(4-(4-hydroxypiperidine-1-yl)-6-methylpyrimidine-2-yl)thioacetyl]-mutilin monohydrate, C32H49N3O6S
C32H49N3O6S, orthorhombic, P212121 (no. 19), a = 9.2618(2) Å, b = 12.4066(2) Å, c = 27.2256(5) Å, V = 3128.42(12) Å3, Z = 4, R gt (F) = 0.0517, wR ref (F 2) = 0.1355, T = 173.20(2) K.
- Open Access
- 17 November 2021
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (1) , 149-151
Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2 N:N′)-bis(4-bromobenzoate-κ1 O)zinc(II)], C64H44Br4N8O8Zn2
C64H44Br4N8O8Zn2, monoclinic, P21/c (No. 14), a = 6.6263(5) Å, b = 24.355(2) Å, c = 18.2418(15) Å, β = 96.433(2)°, V = 2925.4(4) Å3, Z = 2, R gt (F) = 0.0400, wR ref (F 2) = 0.1302, T = 296(2) K.
- 17 November 2021
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (1) , 149-151
Open AccessCrystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2 N:N′)-bis(4-bromobenzoate-κ1 O)zinc(II)], C64H44Br4N8O8Zn2
C64H44Br4N8O8Zn2, monoclinic, P21/c (No. 14), a = 6.6263(5) Å, b = 24.355(2) Å, c = 18.2418(15) Å, β = 96.433(2)°, V = 2925.4(4) Å3, Z = 2, R gt (F) = 0.0400, wR ref (F 2) = 0.1302, T = 296(2) K.
- Open Access
- 16 November 2021
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (1) , 65-66
Crystal structure of (4-chlorophenyl)(4-hydroxyphenyl)methanone, C13H9ClO2
C13H9ClO2, monoclinic, P21 (No. 4), a = 6.5465(9) Å, b = 8.0647(11) Å, c = 10.8476(15) Å, β = 105.591(3)°, V = 551.63(13) Å3, Z = 2, R gt (F) = 0.0532, wR ref (F 2) = 0.1507, T = 296(2) K.
- 16 November 2021
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (1) , 65-66
Open AccessCrystal structure of (4-chlorophenyl)(4-hydroxyphenyl)methanone, C13H9ClO2
C13H9ClO2, monoclinic, P21 (No. 4), a = 6.5465(9) Å, b = 8.0647(11) Å, c = 10.8476(15) Å, β = 105.591(3)°, V = 551.63(13) Å3, Z = 2, R gt (F) = 0.0532, wR ref (F 2) = 0.1507, T = 296(2) K.
- Open Access
Synthesis and Biological Evaluation of New Pleuromutilin Derivatives as Antibacterial Agents
Several pleuromutilin derivatives possessing thiadiazole moieties were synthesized via acylation reactions under mild conditions. The in vitro antibacterial activities of the derivatives against methicillin-resistant S. aureus, methicillin-resistant S. epidermidis, S. aureus, S. epidermidis, E. coli, and B. cereus were tested by the agar dilution method and Oxford cup assay. All the screened compounds displayed potent activity. Compound 6d was the most active antibacterial agent because of its lowest MIC value and largest inhibition zone. Docking experiments were performed to understand the possible mode of the interactions between the derivatives and 50S ribosomal subunit. Moreover, the absorption, distribution, metabolism, excretion and toxicity properties of the synthesized compounds were analyzed after prediction using the Advanced Chemistry Development/Percepta Platform available online.
Open AccessSynthesis and Biological Evaluation of New Pleuromutilin Derivatives as Antibacterial Agents
Several pleuromutilin derivatives possessing thiadiazole moieties were synthesized via acylation reactions under mild conditions. The in vitro antibacterial activities of the derivatives against methicillin-resistant S. aureus, methicillin-resistant S. epidermidis, S. aureus, S. epidermidis, E. coli, and B. cereus were tested by the agar dilution method and Oxford cup assay. All the screened compounds displayed potent activity. Compound 6d was the most active antibacterial agent because of its lowest MIC value and largest inhibition zone. Docking experiments were performed to understand the possible mode of the interactions between the derivatives and 50S ribosomal subunit. Moreover, the absorption, distribution, metabolism, excretion and toxicity properties of the synthesized compounds were analyzed after prediction using the Advanced Chemistry Development/Percepta Platform available online.